Orchev Pharma is an API manufacturer based in India. It holds 4 active US drug master files across a filed portfolio of 2 molecules. Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 21 June 2024 as VAI. Customs aggregates show $3.0M of exports covering 148 molecules to 38 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Rajkot, India | 3009214844 |
| Rajkot, India | Not on file |
| ra jkot, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Famotidine | US FDA | 2 |
| Ranitidine | US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | None | 2 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $3.0M | 38 |
| 2024 | Not reported | $3.5M | 40 |
| 2023 | Not reported | $2.6M | 32 |
| 2022 | Not reported | $1.5M | 27 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Orchev Pharma comes back tiered against every other supplier able to file there.
Start for free